Uncategorized

27 тэрбум америк доллар луйвардсан үл хөдлөхийн захирал эмэгтэй Лан-д Вьетнамын шүүх цаазын ял өгчээ

admin
Read Time:1 Minute, 0 Second

Вьетнамын үл хөдлөх хөрөнгийн томоохон компанийн эзэн эмэгтэйд өчигдөр Хо Ши Мин хотын шүүх цаазын ял оноожээ.

Түүний үйлдсэн хэрэг нь Вьетнамын түүхэн дэх хамгийн том, Зүүн Өмнөд Азийн орнуудад гарсан хамгийн том санхүүгийн луйвруудын нэг юм.

Лан тухайн банкны удирдлагад шууд оролцоогүй ч өөрийн төлөөний этгээдүүдээр дамжуулан 91.5 хувийг нь эзэмшиж, өөрийн халхавч компаниудаар дамжуулан нийтдээ 2,500 гаруй удаа зээл авч завшсан байна.

Түүний луйвардсан мөнгөний хэмжээ $12.5 тэрбум буюу Вьетнам улсын 2022 оны үндэсний дотоодын нийт бүтээгдэхүүний 3 орчим хувьтай тэнцжээ.

Түүний банканд учруулсан нийт хохирол нь  $27 тэрбум орчим гэж прокурорууд дүгнэсэн байна.

Өчигдөр бас энэ хэрэгт холбогдсон “Saigon Commercial Bank” банкны зарим удирдлагууд болон Вьетнамын төв банкны албан тушаалтан бүх насаар хоригдох ял сонсжээ.

Ланы гэр бүлийн гишүүд мөн шийтгүүлсэн байна. Тухайлбал түүний нөхөр Эрик Чу есөн жил, ойрын хамаатан Чуон Хуэ Ван 17 жил шоронд хоригдох ял тус тус сонсжээ.

Вьетнам улсад цаазын ялыг зөвхөн хүн амины хэрэг, хар тамхины хэрэгт оноодог. Харин санхүүгийн луйвар, авлигын хэрэгт оноож байгаагүй юм.

Вьетнамын эрх баригчид авлигын эсрэг тэмцэлдээ хатуу шийдвэр гаргаж буй нь Лан-гийн хэрэг юм.

 

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
0 0

Average Rating

5 Star
7%
4 Star
36%
3 Star
7%
2 Star
29%
1 Star
21%
2.80
(Add your review)

64 thoughts on “27 тэрбум америк доллар луйвардсан үл хөдлөхийн захирал эмэгтэй Лан-д Вьетнамын шүүх цаазын ял өгчээ”

  63. Dianabol And Testosterone Enanthate Cycle: Administraton, Dosages And Results Online Academy Of Judaica Humanitarian Sciences Studies Education Made Easier

    # The 10‑Week Testosterone + Trenbolone Stack: A Comprehensive Guide

    ## Overview

    This stack is designed for experienced users who are comfortable with advanced anabolic protocols
    and understand the risks involved. It pairs **Testosterone Enanthate** (or another long‑acting testosterone
    ester) with **Trenbolone Acetate**, aiming to provide a synergistic blend of muscle growth, strength gains, and improved recovery.

    > **Important:** This guide is for informational purposes only.

    Always consult a qualified healthcare professional before beginning any
    anabolic regimen. Use caution and follow local regulations regarding controlled substances.

    —

    ## 1. Hormones & Dosage

    | Compound | Typical Dosage (per week) | Rationale |
    |———-|—————————|———–|
    | **Testosterone Enanthate** | 200–400 mg/week | Sustains anabolic environment;
    helps maintain natural testosterone levels and prevents hypogonadism.
    |
    | **Testosterone Cypionate** | 0–200 mg/week (optional) | Alternative ester; longer half-life, but less commonly
    used in this combo. |
    | **Testosterone Propionate** | 50–100 mg/day (optional) |
    Short‑acting ester for daily cycling; may increase anabolic activity with minimal
    side effects. |
    | **Testosterone Undecanoate (Deca‑Durabolin)** | 250 mg every 4–6 weeks | Long‑acting ester that provides sustained
    testosterone support and reduces injection frequency.
    |

    ### Key Points

    – **Combination Strategy**
    – Use a fast‑acting ester (propionate) for short, high‑dose anabolic windows.

    – Pair with a long‑acting ester (undecanoate or undecanoate) to maintain baseline
    testosterone levels without frequent injections.

    – **Injection Frequency**
    – Fast‑acting esters require daily or every‑other‑day injections during the active cycle.

    – Long‑acting esters can be administered monthly, reducing
    overall injection burden.

    – **Dose Management**
    – Start with lower doses of fast‑acting ester and titrate upward while monitoring blood
    testosterone levels to avoid supraphysiological peaks that may induce side effects (e.g., gynecomastia).

    —

    ## 3. Blood Testosterone Levels: How the Body Responds

    ### Normal Physiologic Range
    – **Men**: ~300–1,000 ng/dL (~10–35 nmol/L)
    – **Women**: ~15–70 ng/dL (0.5–2.4 nmol/L)

    When testosterone is administered orally:

    | Timing | Approximate Peak Concentration | Relative
    to Physiologic Range |
    |——–|——————————–|——————————|
    | 30 min post‑dose | 500–1,200 ng/dL (≈15–35 nmol/L) | Within or slightly above male range; well below female range |
    | 2 h post‑dose | 300–800 ng/dL (≈9–24 nmol/L) | Similar to baseline male
    levels |
    | 4–6 h post‑dose | 150–400 ng/dL (≈5–13 nmol/L) | Near lower end of
    normal range |

    – **Peak concentrations** are reached quickly and remain safely below the toxic
    thresholds that would affect females.
    – The drug’s half‑life (~3–4 hours for most oral agents) ensures it clears within ~12 hours, minimizing any prolonged hormonal exposure.

    —

    ## 5. Practical Implications

    | Aspect | What It Means for Women |
    |——–|————————-|
    | **Drug absorption** | Oral dosing works normally; no need to adjust timing or
    formulation. |
    | **Metabolism** | CYP3A4‑mediated metabolism is typical; standard drug–drug interaction rules
    apply. |
    | **Side‑effect profile** | Common adverse events (nausea, dizziness) are similar across genders;
    no special gender‑specific monitoring required.
    |
    | **Hormonal impact** | Short‑term, low‑dose exposure does
    not alter menstrual cycle or pregnancy risk. |
    | **Pregnancy & lactation** | In general, most oral
    agents are acceptable during pregnancy if benefits outweigh risks; however,
    specific drugs may be contraindicated—consult medication guide and obstetrician. |

    —

    ## Practical Takeaways for the Pharmacist

    | Situation | What to Do |
    |———–|————|
    | **A woman is on an oral contraceptive and asks about a new prescription** | Review potential
    drug‑drug interactions (e.g., certain antibiotics,
    antiepileptics). Counsel her on whether the medication may lower contraceptive
    efficacy. |
    | **An outpatient female patient with chronic illness requests counseling on medication adherence** | Use motivational interviewing; highlight benefits
    for fertility or pregnancy if relevant; consider a pillbox or reminder
    app. |
    | **A pregnant woman is requesting over‑the‑counter meds (e.g., acetaminophen)** | Verify dosing limits,
    advise against NSAIDs after 20 weeks, and recommend only FDA‑approved formulations.
    |
    | **A patient on hormonal therapy wants to know about side effects** | Discuss breast tenderness, mood
    changes, risk of thromboembolism; provide written material for
    her reference. |

    —

    ## 3. Key Counseling Points

    | Medication Class | Typical Use in Women | Counseling Highlights |
    |——————-|———————-|———————–|
    | **Oral Contraceptives (COCs)** | Birth control, acne treatment, dysmenorrhea | •
    Take at the same time each day.
    • Carry backup contraception if missed dose > 2 days.
    • Discuss risk of blood clots—avoid smoking, prolonged immobility.

    • Monitor for side‑effects: mood swings, breast tenderness.

    |
    | **Progestin‑only Pills (POP)** | Same indications as COCs but suitable for nursing women or those who
    cannot tolerate estrogen | • Must be taken at the same
    time daily.
    • If missed > 3 hours, use backup method for next 48 h.

    • Side‑effects include irregular bleeding.
    |
    | **Hormonal IUD (levonorgestrel)** | Long‑term contraception (up to 5–7 years) | • Minimal estrogen exposure—safe during
    pregnancy risk periods.
    • May reduce heavy menstrual bleeding; rare spotting after insertion. |
    | **Combined Oral Contraceptive (COC) with progestin-only** |
    For women who need daily dosing but have contraindications for estrogen | • Progestin-only pills require strict timing; missing a dose can lead to
    pregnancy.
    • No estrogen-related side effects, but may cause irregular bleeding.

    |
    | **Implantable progestin rod** | 3–5 years of contraception | • No estrogen exposure; minimal effect on other medications.

    |

    ### Key Points

    – **Estrogen is the major contributor to interactions with hormonal contraceptives** (e.g., anticoagulants,
    enzyme-inducing drugs).
    – **Progestin-only methods** tend to have fewer interactions but require strict adherence and may
    still interact via CYP3A4 induction/inhibition.
    – **Combination methods** (estrogen + progestin) have the highest risk for drug‑drug interactions but
    also the greatest efficacy.

    —

    ## 2. Interaction Summary with Key Medications

    Below is a concise table summarizing interactions between hormonal contraceptives and selected classes of medications that are commonly used by patients who may
    be on anticoagulants or other drugs:

    | Medication Class | Mechanism of Interaction | Effect
    on Hormonal Contraceptive |
    |——————-|————————–|———————————-|
    | **Anticoagulants** (warfarin, DOACs) | Warfarin inhibits
    vitamin K–dependent clotting factors; estrogen can increase clotting factor
    production → additive effect. DOACs are unaffected
    by estrogen but may have increased risk of thrombotic events when combined with estrogen. |
    ↑ Risk of thrombosis; monitor INR for warfarin users. |
    | **Antiepileptics** (carbamazepine, phenytoin, phenobarbital) | Induce CYP3A4 → increased metabolism of estrogen/progesterone
    → decreased efficacy of oral contraceptives.
    | Reduced contraceptive effectiveness; consider backup
    methods or non-hormonal contraception. |
    | **Antibiotics** (erythromycin, clarithromycin) | Inhibit CYP3A4 → ↑ estrogen levels → risk of side effects like
    nausea, edema. | Monitor for adverse effects.

    |
    | **Statins** (simvastatin, lovastatin) | Metabolized by CYP3A4; combined with oral contraceptives may increase statin plasma levels →
    potential myopathy. | Check drug interactions; adjust doses if necessary.
    |
    | **Anticonvulsants** (phenytoin, carbamazepine) |
    Induce hepatic enzymes -> increased estrogen metabolism -> reduced efficacy of contraceptives.
    | Consider alternative contraception or enzyme inhibitors.
    |

    —

    ## 4. Practical Recommendations for Clinicians

    | Step | What to Do | Why It Matters |
    |——|————|—————-|
    | **A. Identify drug class** | Review the patient’s
    medication list for classes known to interfere
    with estrogen metabolism (e.g., rifampicin, carbamazepine).
    | Early detection prevents ineffective contraception. |
    | **B. Check drug–drug interactions** | Use a reliable interaction checker (e.g.,
    Micromedex, Lexicomp) to confirm whether the drug
    enhances estrogen clearance or inhibits its action. | Avoid prescribing contraindicated combinations.

    |
    | **C. Decide on alternative contraception** | For patients on interacting drugs:
    1. Consider copper IUD (non‑hormonal).
    2. Use barrier methods + emergency contraception as
    backup.
    3. Evaluate systemic options that do not rely on estrogen metabolism (e.g., progestin‑only pills,
    implants, injections). | Provide effective, user‑friendly alternatives.
    |
    | **D. Counsel and document** | Explain risks
    of contraceptive failure; provide written instructions for emergency contraception; record the plan in the chart.
    | Ensure patient safety and legal compliance. |

    —

    ## 3️⃣ Key Take‑aways

    1. **Interaction Matters:** Many oral contraceptives depend on hepatic
    metabolism that can be inhibited by drugs like certain antibiotics or antifungals.

    2. **Failure Risk:** Inhibition of estrogen clearance may paradoxically reduce effectiveness, leading to unintended pregnancy.

    3. **Alternative Options:**
    * Progestin‑only pills, injections (Depo‑Provera), implants, intrauterine devices (levonorgestrel IUD) are largely unaffected by these drug
    interactions.
    * If a patient must take an interacting medication and wants contraception, consider switching
    to one of the above options.
    4. **Patient Counseling:** Always ask about current medications before prescribing oral contraceptives; review any
    upcoming treatments that might affect hormonal levels.

    **Takeaway:**
    When patients are prescribed drugs known to interfere with estrogen metabolism (e.g., certain antibiotics, antifungals, antiepileptics), consider using non‑oral or progestin‑only contraceptive methods to maintain effective birth control and
    avoid unintended pregnancy.

    —

    *Feel free to adapt this note for your specific patient scenario.*

    References:

    dianabol cycle log

Leave a Reply

Your email address will not be published. Required fields are marked *

More Stories

АНУ дахь Hyundai-LG-ийн батерейны үйлдвэрээс баригдсан 300 гаруй Солонгос ажилчдаа Солонгос улс Korean Air-ийн онгоцоор авна

АНУ-д баривчлагдсан Өмнөд Солонгосын ажилчдыг эх оронд нь буцаахаар Өмнөд Солонгосоос тусгай нислэг илгээв Өмнөд Солонгосын Korean Air Лхагва гарагт...

admin